D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
QNCX holding history
Quince Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
QNCX overviewAll 13F holders of QNCXFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −317,517−100.0% | Sold out | Holders |
| Q2 2022 | 317,517 | $705.0K | <0.1% | +76,617+31.8% | Added | Holders |
| Q1 2022 | 240,900 | $1.49M | <0.1% | +19,549+8.8% | Added | Holders |
| Q4 2021 | 221,351 | $2.79M | <0.1% | +205,341+1,282.6% | Added | Holders |
| Q3 2021 | 16,010 | $1.47M | <0.1% | +11,500+255.0% | Added | Holders |
| Q2 2021 | 4,510 | $239.0K | <0.1% | +4,510 | New | Holders |